感染症と治療ジャーナル

抽象的な

HCV Infection on Lymphoid Neoplasm

Yutaka Tsutsumi, Yoshiya Yamamoto, Shinichi Ito, Takahiro Sekine, Satomi Matsuoka, Hirohito Naruse, and Takanori Teshima

Since there is a suggested a link between HCV and liver cancer, attempts are currently being made to discover new drugs that can advance the treatment of hepatitis C and prevent it from progressing to liver cancer. On the other hand, in the treatment of lymphoma, it has been pointed out that HCV is associated with HCV reactivation and lymphoproliferative diseases such as lymphoma. In this review, we will summarize the relationship between lymphoproliferative diseases and hepatitis due to reactivation of HCV during treatment with rituximab.